Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection.

Murayama A, Momose H, Yamada N, Hoshi Y, Muramatsu M, Wakita T, Ishimaru K, Hamaguchi I, Kato T.

J Clin Virol. 2019 Aug;117:37-42. doi: 10.1016/j.jcv.2019.05.011. Epub 2019 May 29.

PMID:
31176210
2.

Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice.

Doi A, Hikita H, Kai Y, Tahata Y, Saito Y, Nakabori T, Yamada R, Kodama T, Sakamori R, Murayama A, Nitta S, Asahina Y, Suemizu H, Tatsumi T, Kato T, Takehara T.

J Gastroenterol. 2019 May;54(5):449-458. doi: 10.1007/s00535-018-01541-x. Epub 2019 Jan 25.

PMID:
30684016
3.

Establishment of Replication-Competent HCV Strain with Minimum Modifications.

Kato T, Murayama A, Wakita T.

Methods Mol Biol. 2019;1911:73-83. doi: 10.1007/978-1-4939-8976-8_4.

PMID:
30593618
4.

Central nervous system involvement in patients with critical illness polyneuropathy.

Murayama A, Sugaya K, Shimizu T, Sunami Y, Tobisawa S, Isozaki E.

J Neurol Sci. 2019 Jan 15;396:216-218. doi: 10.1016/j.jns.2018.11.023. Epub 2018 Nov 22. No abstract available.

PMID:
30508761
5.

Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein.

Murayama A, Saitoh H, Takeuchi A, Yamada N, Matsumura T, Shiina M, Muramatsu M, Wakita T, Imawari M, Kato T.

Antiviral Res. 2018 Dec;160:55-63. doi: 10.1016/j.antiviral.2018.10.014. Epub 2018 Oct 16.

PMID:
30339849
6.

Evaluation of antiviral effects of novel NS5A inhibitors in hepatitis C virus cell culture system with full-genome infectious clones.

Murayama A, Fujiwara K, Yamada N, Shiina M, Aly HH, Masaki T, Muramatsu M, Wakita T, Kato T.

Antiviral Res. 2018 Oct;158:161-170. doi: 10.1016/j.antiviral.2018.08.008. Epub 2018 Aug 15.

PMID:
30118732
7.

IL-1β/ATF3-mediated induction of Ski2 expression enhances hepatitis B virus x mRNA degradation.

Shiromoto F, Aly HH, Kudo H, Watashi K, Murayama A, Watanabe N, Zheng X, Kato T, Chayama K, Muramatsu M, Wakita T.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1854-1860. doi: 10.1016/j.bbrc.2018.07.126. Epub 2018 Jul 25.

PMID:
30055801
8.

Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection.

Momose H, Matsuoka S, Murayama A, Yamada N, Okuma K, Ikebe E, Hoshi Y, Muramatsu M, Wakita T, Toyota K, Kato T, Hamaguchi I.

J Clin Virol. 2018 Aug;105:97-102. doi: 10.1016/j.jcv.2018.06.008. Epub 2018 Jun 11.

PMID:
29940422
9.

Two Pelvic Masses.

Kondo T, Murayama A.

N Engl J Med. 2018 Feb 22;378(8):752. doi: 10.1056/NEJMicm1708836. No abstract available.

10.

Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling.

Sugiyama R, Murayama A, Nitta S, Yamada N, Tasaka-Fujita M, Masaki T, Aly HH, Shiina M, Ryo A, Ishii K, Wakita T, Kato T.

Oncotarget. 2017 Dec 21;9(5):5627-5640. doi: 10.18632/oncotarget.23562. eCollection 2018 Jan 19.

11.

Resistance mutations of hepatitis B virus in entecavir-refractory patients.

Yamada N, Sugiyama R, Nitta S, Murayama A, Kobayashi M, Okuse C, Suzuki M, Yasuda K, Yotsuyanagi H, Moriya K, Koike K, Wakita T, Kato T.

Hepatol Commun. 2017 Mar 9;1(2):110-121. doi: 10.1002/hep4.1022. eCollection 2017 Apr.

12.

Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.

Manabe O, Kroenke M, Aikawa T, Murayama A, Naya M, Masuda A, Oyama-Manabe N, Hirata K, Watanabe S, Shiga T, Katoh C, Tamaki N.

J Nucl Cardiol. 2019 Jun;26(3):909-918. doi: 10.1007/s12350-017-1122-6. Epub 2017 Dec 14.

PMID:
29243072
13.

Synchronized Collective Proton-Assisted Electron Transfer in Solid State by Hydrogen-Bonding Ru(II)/Ru(III) Mixed-Valence Molecular Crystals.

Tadokoro M, Hosoda H, Inoue T, Murayama A, Noguchi K, Iioka A, Nishimura R, Itoh M, Sugaya T, Kamebuchi H, Haga MA.

Inorg Chem. 2017 Jul 17;56(14):8513-8526. doi: 10.1021/acs.inorgchem.7b01256. Epub 2017 Jul 6.

PMID:
28682602
14.

Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.

Murayama A, Sugiyama N, Suzuki R, Moriyama M, Nakamura N, Mochizuki H, Wakita T, Kato T.

J Virol. 2017 Jan 31;91(4). pii: e02124-16. doi: 10.1128/JVI.02124-16. Print 2017 Feb 15.

15.

B Cell-Based Seamless Engineering of Antibody Fc Domains.

Hashimoto K, Kurosawa K, Murayama A, Seo H, Ohta K.

PLoS One. 2016 Dec 1;11(12):e0167232. doi: 10.1371/journal.pone.0167232. eCollection 2016.

16.

Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents.

Higuchi K, Hikita H, Murayama A, Yuri D, Kobayakawa N, Takahashi T, Kojima S, Ueno H, Hatakeyama T, Kato A, Tayu M, Oyama E, Sugiyama S, Ishii K, Takahashi H, Kawasaki T.

Chem Pharm Bull (Tokyo). 2016;64(12):1726-1738.

17.

Nanometer scale fabrication and optical response of InGaN/GaN quantum disks.

Lai YC, Higo A, Kiba T, Thomas C, Chen S, Lee CY, Tanikawa T, Kuboya S, Katayama R, Shojiki K, Takayama J, Yamashita I, Murayama A, Chi GC, Yu P, Samukawa S.

Nanotechnology. 2016 Oct 21;27(42):425401. doi: 10.1088/0957-4484/27/42/425401. Epub 2016 Sep 15.

PMID:
27632684
18.

Case of desmoplastic melanoma with lung metastasis maintaining complete response after cessation of nivolumab.

Murayama A, Itoh M, Ito K, Tanito K, Ishida K, Nobeyama Y, Nakagawa H.

J Dermatol. 2017 Mar;44(3):e17-e18. doi: 10.1111/1346-8138.13536. Epub 2016 Jul 27. No abstract available.

PMID:
27461747
19.

Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney.

Murayama A, Sugiyama N, Wakita T, Kato T.

MBio. 2016 Jun 14;7(3). pii: e00273-16. doi: 10.1128/mBio.00273-16.

20.

Effect of Artificial Nerve Conduit Vascularization on Peripheral Nerve in a Necrotic Bed.

Iijima Y, Ajiki T, Murayama A, Takeshita K.

Plast Reconstr Surg Glob Open. 2016 Mar 22;4(3):e665. doi: 10.1097/GOX.0000000000000652. eCollection 2016 Mar.

21.

[Nucleotide and amino acid polymorphisms associated with efficient replication of Hepatitis C virus].

Murayama A, Kato T.

Nihon Rinsho. 2015 Dec;73 Suppl 9:105-10. Japanese. No abstract available.

PMID:
26845912
22.

Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.

Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T.

Sci Rep. 2015 Dec 16;5:17208. doi: 10.1038/srep17208. No abstract available.

23.

Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus.

Matsumura T, Sugiyama N, Murayama A, Yamada N, Shiina M, Asabe S, Wakita T, Imawari M, Kato T.

Hepatol Res. 2016 Aug;46(9):924-32. doi: 10.1111/hepr.12627. Epub 2016 Feb 4.

PMID:
26606891
24.

Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.

Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T.

Sci Rep. 2015 Sep 14;5:13994. doi: 10.1038/srep13994. Erratum in: Sci Rep. 2015;5:17208. Masaski, Takahiro [corrected to Masaki, Takahiro].

25.

NEURONAL DEVELOPMENT. Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord.

Guy AT, Nagatsuka Y, Ooashi N, Inoue M, Nakata A, Greimel P, Inoue A, Nabetani T, Murayama A, Ohta K, Ito Y, Aoki J, Hirabayashi Y, Kamiguchi H.

Science. 2015 Aug 28;349(6251):974-7. doi: 10.1126/science.aab3516.

26.

Benzo[c,d]indole-Containing Aza-BODIPY Dyes: Asymmetrization-Induced Solid-State Emission and Aggregation-Induced Emission Enhancement as New Properties of a Well-Known Chromophore.

Shimizu S, Murayama A, Haruyama T, Iino T, Mori S, Furuta H, Kobayashi N.

Chemistry. 2015 Sep 7;21(37):12996-3003. doi: 10.1002/chem.201501464. Epub 2015 Jul 17.

PMID:
26212774
27.

[Derogating victims and dehumanizing perpetrators: functions of two types of beliefs in a just world].

Murayama A, Miura A.

Shinrigaku Kenkyu. 2015 Apr;86(1):1-9. Japanese.

PMID:
26012259
28.

Light-emitting devices based on top-down fabricated GaAs quantum nanodisks.

Higo A, Kiba T, Tamura Y, Thomas C, Takayama J, Wang Y, Sodabanlu H, Sugiyama M, Nakano Y, Yamashita I, Murayama A, Samukawa S.

Sci Rep. 2015 Mar 20;5:9371. doi: 10.1038/srep09371.

29.

Perturbation of ribosome biogenesis drives cells into senescence through 5S RNP-mediated p53 activation.

Nishimura K, Kumazawa T, Kuroda T, Katagiri N, Tsuchiya M, Goto N, Furumai R, Murayama A, Yanagisawa J, Kimura K.

Cell Rep. 2015 Mar 3;10(8):1310-23. doi: 10.1016/j.celrep.2015.01.055. Epub 2015 Feb 26.

30.

Temperature dependence of the radiative recombination time in ZnO nanorods under an external magnetic field of 6 T.

Lee W, Kiba T, Murayama A, Sartel C, Sallet V, Kim I, Taylor RA, Jho YD, Kyhm K.

Opt Express. 2014 Jul 28;22(15):17959-67. doi: 10.1364/OE.22.017959.

PMID:
25089415
31.

Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells.

Sung PS, Murayama A, Kang W, Kim MS, Yoon SK, Fukasawa M, Kondoh M, Kim JS, Kim H, Kato T, Shin EC.

J Virol. 2014 Aug;88(16):9233-44. doi: 10.1128/JVI.01428-14. Epub 2014 Jun 4.

32.

Massive thrombus in the left ventricle: a case report.

Udagawa C, Akima T, Horiuchi F, Nishida M, Tachikawa K, Izawa M, Kanki H, Murayama A.

J Echocardiogr. 2014 Jun;12(2):81-2. doi: 10.1007/s12574-014-0206-4. Epub 2014 Feb 22. No abstract available.

PMID:
27279056
33.

Single strain isolation method for cell culture-adapted hepatitis C virus by end-point dilution and infection.

Sugiyama N, Murayama A, Suzuki R, Watanabe N, Shiina M, Liang TJ, Wakita T, Kato T.

PLoS One. 2014 May 21;9(5):e98168. doi: 10.1371/journal.pone.0098168. eCollection 2014.

34.

Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-α in infectious virus production.

Masaki T, Matsunaga S, Takahashi H, Nakashima K, Kimura Y, Ito M, Matsuda M, Murayama A, Kato T, Hirano H, Endo Y, Lemon SM, Wakita T, Sawasaki T, Suzuki T.

J Virol. 2014 Jul;88(13):7541-55. doi: 10.1128/JVI.03170-13. Epub 2014 Apr 23.

35.

Hepatic rRNA transcription regulates high-fat-diet-induced obesity.

Oie S, Matsuzaki K, Yokoyama W, Tokunaga S, Waku T, Han SI, Iwasaki N, Mikogai A, Yasuzawa-Tanaka K, Kishimoto H, Hiyoshi H, Nakajima Y, Araki T, Kimura K, Yanagisawa J, Murayama A.

Cell Rep. 2014 May 8;7(3):807-20. doi: 10.1016/j.celrep.2014.03.038. Epub 2014 Apr 18.

36.

Photophysical properties and biocompatibility of Photoluminescent Y2O3:Eu nanoparticles in polymethylmetacrylate matrix.

Abe S, Hamba Y, Iwadera N, Yamagata S, Yawaka Y, Uo M, Iida J, Kiba T, Murayama A, Watari F.

J Nanosci Nanotechnol. 2014 Apr;14(4):2891-4.

PMID:
24734706
37.

Evolutionarily dynamic alternative splicing of GPR56 regulates regional cerebral cortical patterning.

Bae BI, Tietjen I, Atabay KD, Evrony GD, Johnson MB, Asare E, Wang PP, Murayama AY, Im K, Lisgo SN, Overman L, Šestan N, Chang BS, Barkovich AJ, Grant PE, Topçu M, Politsky J, Okano H, Piao X, Walsh CA.

Science. 2014 Feb 14;343(6172):764-8. doi: 10.1126/science.1244392.

38.

Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.

Han SI, Komatsu Y, Murayama A, Steffensen KR, Nakagawa Y, Nakajima Y, Suzuki M, Oie S, Parini P, Vedin LL, Kishimoto H, Shimano H, Gustafsson JÅ, Yanagisawa J.

Hepatology. 2014 May;59(5):1791-802. doi: 10.1002/hep.26951. Epub 2014 Mar 27.

PMID:
24277692
39.

Fetal sulcation and gyrification in common marmosets (Callithrix jacchus) obtained by ex vivo magnetic resonance imaging.

Sawada K, Hikishima K, Murayama AY, Okano HJ, Sasaki E, Okano H.

Neuroscience. 2014 Jan 17;257:158-74. doi: 10.1016/j.neuroscience.2013.10.067. Epub 2013 Nov 9.

PMID:
24220690
40.

A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J.

J Clin Invest. 2013 Nov;123(11):4579-94. doi: 10.1172/JCI67804. Epub 2013 Oct 25.

41.

Effect of decision confidence on the evaluation of conflicting decisions in a social context.

Kimura K, Murayama A, Miura A, Katayama J.

Neurosci Lett. 2013 Nov 27;556:176-80. doi: 10.1016/j.neulet.2013.09.020. Epub 2013 Sep 16.

PMID:
24051339
42.

Quantum size effects in GaAs nanodisks fabricated using a combination of the bio-template technique and neutral beam etching.

Tamura Y, Kaizu T, Kiba T, Igarashi M, Tsukamoto R, Higo A, Hu W, Thomas C, Fauzi ME, Hoshii T, Yamashita I, Okada Y, Murayama A, Samukawa S.

Nanotechnology. 2013 Jul 19;24(28):285301. doi: 10.1088/0957-4484/24/28/285301. Epub 2013 Jun 20.

PMID:
23787817
43.

Acute aortic regurgitation due to aortic dissection confined to the sinus of Valsalva.

Kanki H, Shimamura Y, Kageyama T, Nagatomo Y, Akima T, Ishikawa S, Maisawa K, Murayama A.

J Echocardiogr. 2013 Jun;11(2):72-4. doi: 10.1007/s12574-013-0169-x. Epub 2013 Feb 9.

PMID:
27278515
44.

Endoscopic papillary balloon dilation for a 7-year-old girl with choledocholithiasis.

Sogo T, Kondo T, Tsunoda T, Murayama A, Komatsu H, Inui A, Fujisawa T.

Pediatr Int. 2013 Apr;55(2):e1-3. doi: 10.1111/j.1442-200X.2012.03685.x.

PMID:
23679173
45.

Temperature dependence of time-resolved photoluminescence in closely packed alignment of Si nanodisks with SiC barriers.

Kiba T, Mizushima Y, Igarashi M, Huang CH, Samukawa S, Murayama A.

Nanoscale Res Lett. 2013 May 10;8(1):223. doi: 10.1186/1556-276X-8-223.

46.

HDAC3 regulates stability of estrogen receptor α mRNA.

Oie S, Matsuzaki K, Yokoyama W, Murayama A, Yanagisawa J.

Biochem Biophys Res Commun. 2013 Mar 8;432(2):236-41. doi: 10.1016/j.bbrc.2013.02.007. Epub 2013 Feb 10.

PMID:
23402757
47.

A subclone of HuH-7 with enhanced intracellular hepatitis C virus production and evasion of virus related-cell cycle arrest.

Murayama A, Sugiyama N, Yoshimura S, Ishihara-Sugano M, Masaki T, Kim S, Wakita T, Mishiro S, Kato T.

PLoS One. 2012;7(12):e52697. doi: 10.1371/journal.pone.0052697. Epub 2012 Dec 20.

48.

[Cardiac papillary fibroelastoma on the Chiari's network of a 3-month-old baby; report of a case].

Murayama A, Tateishi A, Kawada M, Kuwata T, Matsubara S, Shiraishi H, Misawa Y.

Kyobu Geka. 2012 Dec;65(13):1169-71. Japanese.

PMID:
23202715
49.

Plasmonic enhancements of photoluminescence in hybrid Si nanostructures with Au fabricated by fully top-down lithography.

Nakaji K, Li H, Kiba T, Igarashi M, Samukawa S, Murayama A.

Nanoscale Res Lett. 2012 Nov 16;7(1):629. doi: 10.1186/1556-276X-7-629.

50.

Picosecond carrier dynamics induced by coupling of wavefunctions in a Si-nanodisk array fabricated by neutral beam etching using bio-nano-templates.

Kiba T, Mizushima Y, Igarashi M, Samukawa S, Murayama A.

Nanoscale Res Lett. 2012 Oct 24;7(1):587. doi: 10.1186/1556-276X-7-587.

Supplemental Content

Loading ...
Support Center